文献速递头颈神经MRPET

基于头颈部MRI的T分期与[18F]FDG PET/CT的N/M分期改善原发性鼻咽癌的预后分层

Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
PubMed 文献 · Eur Radiol · 2023-06-14

该研究纳入2007年4月至2013年12月连续1013例初治鼻咽癌患者,比较四种TNM分期方法的预后预测能力。结果显示MRI在T分期优于[18F]FDG PET/CT,而[18F]FDG PET/CT在N/M分期优于传统检查;「TMRI + NPET/CT + MPET/CT」分期方法可显著改善长期预后分层。

要点

  • MRI在鼻咽癌T分期上优于[18F]FDG PET/CT(NRI=-0.174,p<0.001)。
  • [18F]FDG PET/CT在N分期(NRI=0.135,p=0.004)和M分期(NRI=0.126,p=0.001)优于传统检查。
  • 「TMRI + NPET/CT + MPET/CT」法预后预测优于「MMP」(NRI=0.079,p=0.007)、「MMC」(NRI=0.190,p<0.001)和「PPP」(NRI=0.107,p<0.001)。

核心结论

  • MRI在T分期优于[18F]FDG PET/CT,[18F]FDG PET/CT在N/M分期优于传统检查;「TMRI + NPET/CT + MPET/CT」分期方法可显著改善鼻咽癌患者的长期预后分层。

研究设计与样本

  • 研究纳入2007年4月至2013年12月连续1013例初治鼻咽癌患者,所有患者均具备完整影像资料,基于四种影像学分期方法重新分期,采用生存曲线、ROC曲线和净重分类改善(NRI)分析评价不同分期方法的预后预测能力。

诊断标准与关键数值

  • [18F]FDG PET/CT在T分期的NRI=-0.174(p<0.001),在N分期的NRI=0.135(p=0.004),在M分期的NRI=0.126(p=0.001)。
  • 「MPP」法对比「MMP」法的NRI=0.079(p=0.007),对比「MMC」法的NRI=0.190(p<0.001),对比「PPP」法的NRI=0.107(p<0.001)。
  • 由[18F]FDG PET/CT升级N分期的患者生存更差(p=0.011)。
  • 根据时间依赖NRI值,随访超过2.5年的患者中改善显著。

临床应用与阅片要点

  • 原文提出「TMRI + NPET/CT + MPET/CT」(「MPP」)这一新的鼻咽癌TNM分期影像检查流程。
  • 「MPP」法可将患者的TNM分期重新分类至更合适的分期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate whether MRI-based T stage (TMRI), [18F]FDG PET/CT-based N (NPET/CT), and M stage (MPET/CT) are superior in NPC patients' prognostic stratification based on long-term survival evidences, and whether TNM staging method involving TMRI + NPET/CT + MPET/CT could improve NPC patients' prognostic stratification.

METHODS: From April 2007 to December 2013, 1013 consecutive untreated NPC patients with complete imaging data were enrolled. All patients' initial stages were repeated based on (1) the NCCN guideline recommended "TMRI + NMRI + MPET/CT" ("MMP") staging method; (2) the traditional "TMRI + NMRI + Mconventional work-up (CWU)" ("MMC") staging method; (3) the single-step "TPET/CT + NPET/CT + MPET/CT" ("PPP") staging method; or (4) the "TMRI + NPET/CT + MPET/CT" ("MPP") staging method recommended in present research. Survival curve, ROC curve, and net reclassification improvement (NRI) analysis were used to evaluate the prognosis predicting ability of different staging methods.

RESULTS: [18F]FDG PET/CT performed worse on T stage (NRI = - 0.174, p < 0.001) but better on N (NRI = 0.135, p = 0.004) and M stage (NRI = 0.126, p = 0.001). The patients whose N stage upgraded by [18F]FDG PET/CT had worse survival (p = 0.011). The "TMRI + NPET/CT + MPET/CT" ("MPP") method performed better on survival prediction when compared with "MMP" (NRI = 0.079, p = 0.007), "MMC" (NRI = 0.190, p < 0.001), or "PPP" method (NRI = 0.107, p < 0.001). The "TMRI + NPET/CT + MPET/CT" ("MPP") method could reclassify patients' TNM stage to a more appropriate stage. The improvement is significant in patients with more than 2.5-years follow-up according to the time-dependent NRI values.

CONCLUSIONS: The MRI is superior to [18F]FDG PET/CT in T stage, and [18F]FDG PET/CT is superior to CWU in N/M stage. The "TMRI + NPET/CT + MPET/CT" ("MPP") staging method could significantly improve NPC patients' long-term prognostic stratification.

CLINICAL RELEVANCE STATEMENT: The present research provided long-term follow-up evidence for benefits of MRI and [18F]FDG PET/CT in TNM staging for nasopharyngeal carcinoma, and proposes a new imaging procedure for TNM staging incorporating MRI-based T stage and [18F]FDG PET/CT-based N and M stage, which significantly improves long-term prognostic stratification for patients with NPC.

KEY POINTS: • The long-term follow-up evidence of a large-scale cohort was provided to evaluate the advantages of MRI, [18F]FDG PET/CT, and CWU in the TNM staging of nasopharyngeal carcinoma. • A new imaging procedure for TNM stage of nasopharyngeal carcinoma was proposed.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Xie, Sun, Zhang, et al. Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma. Eur Radiol. 2023. PMID: 37314471. doi:10.1007/s00330-023-09815-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。